Listen
Languages
Karolinska Institutet and St. Erik Eye Hospital have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration. Novo Nordisk A/S will provide support and SEK 48 million in funding to enable a phase 1 clinical trial where new retinal cells generated from embryonic stem cells will be transplanted into patients. The aim is to develop a completely new cell therapy for this common but currently incurable eye disease.
Advanced dry AMD with geographic atrophy. The black marking shows the area of cell death. Photo: St. Erik Eye Hospital
Responsible Communications department
i
This site uses cookies. A cookie is a small text file stored on the visitor's computer (or other device) and used to improve the functionality of the website. Read more about how we handle cookies.